Team-based Interdisciplinary Cancer Research Training Program promoting horizontal and vertical interdisciplinary collaborations
Our Team-based Interdisciplinary Cancer Research Training (TICaRT) Program offers a unique training opportunity for pre- and postdoctoral trainees to develop interdisciplinary skills in cancer research and experience with transdisciplinary approaches.
How To Apply
Deadline: April 1, 2025
Now recruiting!
Applications are now open for our next cohort.

what makes us Unique
Interdisciplinary Teams
Horizontal & Vertical Collaborations
Near-Peer Mentoring
what we stand for
Objective
The objective of this T32 training program is to provide trainees from a broad range of disciplines the opportunity to develop interdisciplinary skills in cancer research and experience with transdisciplinary approaches.

Premise
Advances in the fundamental understanding of cancer and its clinical management rarely occur in isolation but typically represent team-based research endeavors.
Belief
Early exposure of trainees to interdisciplinary education and training coupled with team-based learning will better position them for successful cancer research careers.
TRAINEE SUCCESS
Ph.D. Pathways
Applying AI to genomics and medicine
Daniel Stribling, who participated in the first cohort of the TICaRT program, has garnered numerous accolades for his research. Upon completion of the UF M.D.-Ph.D. program, he hopes to be part of applying the rapidly advancing fields of AI to genomics and medicine.

Ph.D. Pathways
Increasing cancer screening rates through virtual clinicians
Andrew Maxim, who participated in the first cohort of the TICaRT program, pursued his Ph.D. in the Virtual Experiences Research Group with Benjamin Lok, Ph.D. His main research project is Meet ALEX, which uses a virtual clinician that can speak both English and Spanish to help increase rates of colorectal screening.

Ph.D. Pathways
Harnessing the gut microbiome to enhance immunotherapy
Rachel Newsome, who participated in the first cohort of the TICaRT program, investigates the role of the gut microbiome in patient responses to cancer immunotherapy for lung, colon and brain cancer. Newsome, who earned her Ph.D. through the UF Graduate Program in Biomedical Sciences in the cancer biology concentration, was featured in our Cancer Researchers on the Rise video series.

Contact

Contact
Questions? Please email education@cancer.ufl.edu for additional information.

Support
This program is supported with funding from the National Cancer Institute (Grant # T32 CA257923) and the University of Florida Health Cancer Center.